Recent Updates
Recently added Catalysts
IONS Positive Sentiment

Ionis to hold fourth quarter and full year 2023 financial results webcast Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, February 21st at 11:30 a.m. Eastern Time to ...

Key Takeaway: Ionis Pharmaceuticals will hold a live webcast on February 21, 2024, at 11:30 a.m. ET to discuss its fourth quarter and full year 2023 financial results. The event will be accessible online, with a replay available for a limited time. Ionis continues to innovate in RNA-targeted therapies and has a robust pipeline.
Price reaction · baseline $49.12 (2024-02-06 close) · hit after-hours · 1 other IONS headline(s) in the window, move may be shared
day 0 close · peak
+0.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ionis Pharmaceuticals is hosting a live webcast to discuss financial results.
  • The company has a strong pipeline in neurology and cardiology.
  • Ionis is a pioneer in RNA-targeted medicines.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
4.1%
average across 11 past catalysts
Lead asset
ISIS 113715
Phase 2 · Type 2 Diabetes Mellitus

Full Press Release Details

Webcast scheduled for Wednesday, February 21 at 11:30 a.m. Eastern Time
CARLSBAD, Calif. , Feb. 7, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS ) announced today that it will host a live webcast on Wednesday, February 21 st at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2023 financial results.
The live webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events . A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.
To learn more about Ionis, visit www.ionispharma.com and follow us on X (Twitter) and LinkedIn.

Frequently Asked Questions

When will the Ionis webcast take place?

The Ionis webcast is scheduled for February 21, 2024, at 11:30 a.m. ET.

How can I access the Ionis webcast?

The webcast can be accessed at Ionis's investor relations website.

What will be discussed during the webcast?

The webcast will cover Ionis's fourth quarter and full year 2023 financial results.

Will there be a replay of the webcast?

Yes, a replay will be available for a limited time after the live event.

Last updated: Feb 7, 2024